Implantica Liechtenstein
07.08.2025 - 18:08:57Implantica's RefluxStop™ health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world's leading European Health-Economics Conference
About RefluxStop™
RefluxStop™ is a new innovative treatment that has the potential to spur a paradigm shift in anti-reflux surgery. It's unique mechanism of action differentiates it from standard of care and current surgical solutions. Existing surgical procedures and devices are focused on the Lower Esophageal Sphincter (LES) with a principal assumption that the LES is weak and or improperly functioning thereby not closing properly. These methods encircle the food passageway to support the LES's closing sphincter and are commonly associated with side effects such as swallowing difficulties, inability to belch and vomit and gas bloating. In contrast, the RefluxStop™ device addresses acid reflux without affecting the food passageway.
The RefluxStop™ mechanism of action is focused on reconstructing all three components of the anti-reflux barrier, that if compromised could possibly result in acid reflux. It restores and supports the natural anatomical physiology of the body allowing the body to itself solve the problem with acid reflux.
Newsroom
https://www.implantica.com/media/media-kit
Cost-Effectiveness Analysis of an Implantable Device for Chronic Gastro-Oesophageal Reflux Disease in Sweden: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3787/130704Analysis of Cost-Effectiveness in Switzerland for a New Implantable Device to Treat Chronic Gastroesophageal Reflux Disease: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3788/133117The Cost of Treating Gastroesophageal Reflux Disease: A Systematic Review: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3787/131869A Systematic Review of Quality of Life and Gastroesophageal Reflux Disease: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3785/131910
Media Contact:
Implantica AG
Juanita Eberhart
Senior Director of Marketing
M: +1 925-381-4581
juanita.eberhart@implantica.com
The following files are available for download:
https://mb.cision.com/Main/19732/3876962/2434503.pdf
Implantica’s RefluxStopTM health economic research, showing superior cost-effectiveness, has received top-recognition at ISPOR, the world’s leading European Health-Economics Conference
https://news.cision.com/implantica/i/ispor-poster-murali-top-5percent,c3239925
ISPOR poster Murali top 5percent
https://news.cision.com/implantica/i/microsoftteams-image-8,c3239926
MicrosoftTeams-image 8
https://news.cision.com/implantica/i/logo-transparent-1-8,c3239924
logo transparent 1 8
https://news.cision.com/implantica/i/reluxstop-product,c3239927
ReluxStop Product
View original content:
